Product Information
GNP SINUS-HEADACHE CAPLET is a generic product labeled by AmerisourceBergen, priced at $0.0853 per EA under NDC 46122065862. Its NADAC has been published 282 times since May 12, 2021.
Strength
325; 5 mg/1; mg/1
Manufacturer
AmerisourceBergenNDC
46122065862
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
10/15/2020
Pharmacological Classes
Price Statistics
The NADAC for GNP SINUS-HEADACHE CAPLET has been published 282 times since May 12, 2021, and over the history we have for it it has risen 67.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0853 per EA |
|---|---|
| All-time high | $0.0905 (Mar 15, 2023) |
| All-time low | $0.0488 (Dec 22, 2021) |
| 52-week high | $0.0854 |
| 52-week low | $0.0800 |
| Median price | $0.0753 |
| Average price | $0.0738 |
| Largest weekly change | +45.2% (Feb 22, 2023) |
| Weeks tracked | 282 |
| Tracking since | May 12, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ACETAMINOPHEN and PHENYLEPHRINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-1 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP SINUS-HEADACHE CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for GNP SINUS-HEADACHE CAPLET, manufactured by AmerisourceBergen, is $0.0853 per EA (NDC 46122065862), effective Sep 30, 2026.
How has the price of GNP SINUS-HEADACHE CAPLET changed over time?
Over the history we have for it, the NADAC for GNP SINUS-HEADACHE CAPLET has risen 67.8%. It has been tracked across 282 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for GNP SINUS-HEADACHE CAPLET?
Since May 12, 2021, the NADAC for GNP SINUS-HEADACHE CAPLET has ranged from a low of $0.0488 (Dec 22, 2021) to a high of $0.0905 (Mar 15, 2023), with a median of $0.0753 per EA.
Are there cheaper alternatives to GNP SINUS-HEADACHE CAPLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as GNP SINUS-HEADACHE CAPLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GNP SINUS-HEADACHE CAPLET?
GNP SINUS-HEADACHE CAPLET (NDC 46122065862) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.